Why Walmart’s warning may have more to do with weight-loss drugs than tariffs
Walmart’s stock was falling Thursday as quarterly earnings were expected to decline for the first time in three years, with strength in groceries and GLP-1 drug sales continuing to pressure margins.
Walmart’s stock was falling Thursday as quarterly earnings were expected to decline for the first time in three years, with strength in groceries and GLP-1 drug sales continuing to pressure margins.
